Peptide Report
SS-31 Peptide Report
Catalog report for SS-31, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$79.99 – $150.00 CAD
Common Uses
People commonly discuss SS-31 for mitochondrial support, energy, recovery, and healthy-aging routines, especially where cellular resilience is the main interest.
How It Works
SS-31, also known as elamipretide, targets mitochondria by associating with cardiolipin in the inner mitochondrial membrane. It is studied for stabilizing mitochondrial structure, improving electron-transport efficiency, and reducing oxidative stress.
Storage
Powder form: In lyophilized powder form, SS-31 is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, SS-31 should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full SS-31 protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 10 MG and 50 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 10 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 50 mcg |
| 50 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
25 mg/mL |
Each U-100 unit = 250 mcg |
Syringe Conversion
| Reported amount |
10 MG setup |
50 MG setup |
| 1 mg |
20 units |
4 units |
| 2.5 mg |
50 units |
10 units |
| 5 mg |
100 units |
20 units |
| 10 mg |
200 units |
40 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 1-2.5 mg |
Once daily |
Lower-start reports |
| 5 mg |
Once daily |
Most recurring amount |
| 10 mg |
Once daily in some reports |
Higher experimental use |
Observations
- Community discussions most often centered on mitochondrial function, energy, endurance and recovery goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- Elamipretide/SS-31 remains investigational for many uses; human trial formulations do not validate unregulated products.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.